| Authors: |
Foss DV; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Muldoon JJ; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Nguyen DN; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Carr D; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Sahu SU; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Hunsinger JM; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Wyman SK; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA., Krishnappa N; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA., Mendonsa R; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA., Schanzer EV; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA., Shy BR; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Vykunta VS; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Allain V; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA.; Université de Paris, INSERM UMR976, Hôpital Saint-Louis, Paris, France., Li Z; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Marson A; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. alexander.marson@ucsf.edu.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Diabetes Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. alexander.marson@ucsf.edu., Eyquem J; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Medicine, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Parker Institute for Cancer Immunotherapy, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Department of Microbiology and Immunology, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; UCSF Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu.; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA. justin.eyquem@ucsf.edu., Wilson RC; Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu.; California Institute for Quantitative Biosciences at University of California Berkeley, Berkeley, CA, USA. rosswilson@berkeley.edu. |
